Purchase Warrant Sample Contracts

Establishment Labs Holdings Inc. – Establishment Labs Holdings Inc. Amended and Restated Ordinary Share Purchase Warrant (Void After August 28, 2022) (July 13th, 2018)

Notwithstanding anything to the contrary in this Warrant, upon written notice by the Registered Holder to the Company, the Registered Holder shall have the right, but not the obligation, to waive all or any portion of the Registered Holder's rights under this Warrant. This Warrant is being reissued pursuant to and in accordance with the Prior Warrant. Capitalized terms used and not defined herein shall have the meanings ascribed thereto in that certain Note and Warrant Purchase Agreement dated as of August 28, 2015 by and between the Company and CPH TU, LP.

Auris Medical AG – COMMON SHARE PURCHASE WARRANT AURIS MEDICAL Holding Ag (July 12th, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on June 18, 2020 (the "Termination Date") but not thereafter, to subscribe for and purchase from Auris Medical Holding AG, a company established in Switzerland (the "Company"), up to [______] (as subject to adjustment hereunder, the "Warrant Shares") of registered common shares, nominal value CHF 0.02 per share (each, a "Common Share"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Auris Medical AG – COMMON SHARE PURCHASE WARRANT AURIS MEDICAL Holding Ag (July 12th, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on June 18, 2020 (the "Termination Date") but not thereafter, to subscribe for and purchase from Auris Medical Holding AG, a company established in Switzerland (the "Company"), up to [______] (as subject to adjustment hereunder, the "Warrant Shares") of registered common shares, nominal value CHF 0.02 per share (each, a "Common Share"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Auris Medical AG – COMMON SHARE PURCHASE WARRANT AURIS MEDICAL Holding Ag (July 12th, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on [_______]1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Auris Medical Holding AG, a company established in Switzerland (the "Company"), up to [______] (as subject to adjustment hereunder, the "Warrant Shares") of registered common shares, nominal value CHF 0.02 per share (each, a "Common Share"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Auris Medical AG – COMMON SHARE PURCHASE WARRANT AURIS MEDICAL Holding Ag (July 3rd, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on [_______]1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Auris Medical Holding AG, a company established in Switzerland (the "Company"), up to [______] (as subject to adjustment hereunder, the "Warrant Shares") of registered common shares, nominal value CHF 0.02 per share (each, a "Common Share"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Auris Medical AG – COMMON SHARE PURCHASE WARRANT AURIS MEDICAL Holding Ag (July 3rd, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on June 18, 2020 (the "Termination Date") but not thereafter, to subscribe for and purchase from Auris Medical Holding AG, a company established in Switzerland (the "Company"), up to [______] (as subject to adjustment hereunder, the "Warrant Shares") of registered common shares, nominal value CHF 0.02 per share (each, a "Common Share"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Summit Semiconductor Inc. – Common Units Purchase Warrant Summit Semiconductor, Llc (July 2nd, 2018)

THIS COMMON UNITPURCHASE WARRANT (the "Warrant") certifies that, for value received [*] or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement between the Company and the Holder (the "Purchase Agreement"), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth anniversary of the Original Issue Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Summit Semiconductor, LLC, a Delaware limited liability company (the "Company"), up to [*] Common Units (as subject to adjustment hereunder, the "Warrant Units"); provided, however, the number of Warrant Units exercisable pursuant to this Warrant shall double in the event the Company does not consummate an IPO by June 1, 2017. The purchase price of one Common Unit under this Warrant shall be equal to the Exercise Price, as defined in Section

Summit Semiconductor Inc. – Common Units Purchase Warrant Summit Semiconductor, Llc (July 2nd, 2018)

THIS COMMON UNIT PURCHASE WARRANT (the "Warrant") certifies that, for value received _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement between the Company and the Holder (the "Purchase Agreement"), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth anniversary of the Original Issue Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Summit Semiconductor, LLC, a Delaware limited liability company (the "Company"), up to __________ Common Units (as subject to adjustment hereunder, the "Warrant Units"). The purchase price of one Common Unit under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Summit Semiconductor Inc. – Common Units Purchase Warrant Summit Semiconductor, Llc (July 2nd, 2018)

THIS COMMON UNIT PURCHASE WARRANT (the "Warrant") certifies that, for value received MARCorp Signal, LLC or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement between the Company and the purchasers, including the Holder (the "Purchase Agreement"), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth anniversary of the Original Issue Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Summit Semiconductor, LLC, a Delaware limited liability company (the "Company"), up to that number of Common Units equal to the quotient of (x) the aggregate Principal Amount of the Note (as defined below) divided by (y) the Exercise Price (as defined below) (such number of Common Units to be subject to adjustment hereunder, the "Warrant Units"); provided, however, the number of Warrant Units exerci

Vascular Biogenics Ltd. – FORM OF [SERIES a/Series B] ORDINARY SHARE PURCHASE WARRANT Vascular Biogenics Ltd. (June 27th, 2018)

THIS [SERIES A/SERIES B] ORDINARY SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on ______________1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Vascular Biogenics Ltd., a company organized under the laws of Israel (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Ordinary Shares, NIS 0.01 par value (the "Ordinary Share(s)"), of the Company. The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Stellar Biotechnologies, Inc. – SERIES B COMMON SHARE PURCHASE WARRANT Stellar Biotechnologies, Inc. (May 30th, 2018)

THIS SERIES B COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on May 29, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common shares, no par value per share (the "Common Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Stellar Biotechnologies, Inc. – SERIES a COMMON SHARE PURCHASE WARRANT Stellar Biotechnologies, Inc. (May 30th, 2018)

THIS SERIES A COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on May 29, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common shares, no par value per share (the "Common Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Stellar Biotechnologies, Inc. – SERIES a COMMON SHARE PURCHASE WARRANT Stellar Biotechnologies, Inc. (May 30th, 2018)

THIS SERIES A COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on May 29, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common shares, no par value per share (the "Common Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Retrospettiva Inc – PURCHASE WARRANT Issued To: Paulson Investment Company, LLC Exercisable to Purchase 147,267 Shares of Common Stock Of (May 24th, 2018)

This is to certify that, for value received and subject to the terms and conditions set forth below, the Warrantholder is entitled to purchase, and the Company promises and agrees to sell and issue to the Warrantholder, at any time on or after the Initial Exercise Date and on or before the Expiration Date, up to 147,267 shares of Common Stock at the per share Exercise Price.

Entera Bio Ltd. – Ordinary Share Purchase Warrant Entera Bio Ltd. (May 17th, 2018)

THIS ORDINARY SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, Cede & Co. or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [ ], 2018 (the "Initial Exercise Date") and on or prior to 5:00 p.m., New York City time, on the fifth (5) year anniversary of the Initial Exercise Date, subject to early acceleration as set forth in Section 3(h) below (the "Termination Date") but not thereafter, to subscribe for and purchase from Entera Bio Ltd., a company limited by shares incorporated under the laws of Israel (the "Company"), up to [_______] Ordinary Shares (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depo

Stellar Biotechnologies, Inc. – COMMON SHARE PURCHASE WARRANT Stellar Biotechnologies, Inc. (May 15th, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on May 15, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common shares, no par value per share (the "Common Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Stellar Biotechnologies, Inc. – COMMON SHARE PURCHASE WARRANT Stellar Biotechnologies, Inc. (May 15th, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on May 10, 2023 (the "Termination Date"), provided that, if such date is not a Trading Day, the Termination Date should be the immediately following Trading Day but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common shares, no par value per share (the "Common Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Stellar Biotechnologies, Inc. – PRE-FUNDED COMMON SHARE PURCHASE WARRANT Stellar Biotechnologies, Inc. (May 15th, 2018)

THIS PRE-FUNDED COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") until this Warrant is exercised in full (the "Termination Date"), but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common shares, no par value per share (the "Common Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Stellar Biotechnologies, Inc. – Common Share Purchase Warrant Stellar Biotechnologies, Inc. (May 8th, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on May __, 20231 (the "Termination Date"), provided that, if such date is not a Trading Day, the Termination Date should be the immediately following Trading Day but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common shares, no par value per share (the "Common Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Stellar Biotechnologies, Inc. – Pre-Funded Common Share Purchase Warrant Stellar Biotechnologies, Inc. (May 8th, 2018)

THIS PRE-FUNDED COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") until this Warrant is exercised in full (the "Termination Date"), but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common shares, no par value per share (the "Common Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Stellar Biotechnologies, Inc. – Common Share Purchase Warrant Stellar Biotechnologies, Inc. (May 8th, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the "Termination Date"), provided that, if such date is not a Trading Day, the Termination Date should be the immediately following Trading Day but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common shares, no par value per share (the "Common Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Check-Cap Ltd – Pre-Funded Ordinary Share Purchase Warrant Check-Cap Ltd. (April 25th, 2018)

THIS PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [ISSUE DATE] (the "Initial Exercise Date") until this Warrant is exercised in full (the "Termination Date"), but not thereafter to subscribe for and purchase from Check-Cap Ltd., an Israeli company (the "Company"), up to ______ Ordinary Shares (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Check-Cap Ltd – Series C Ordinary Share Purchase Warrant Check-Cap Ltd. (April 25th, 2018)

THIS SERIES C ORDINARY SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [ISSUE DATE] (the "Initial Exercise Date") and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the "Termination Date"), provided that, if such date is not a Trading Day, the Termination Date should be the immediate following Trading Day but not thereafter, to subscribe for and purchase from Check-Cap Ltd., an Israeli company (the "Company"), up to ______ Ordinary Shares (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

China SXT Pharmaceuticals, Inc. – The Registered Holder of This Purchase Warrant by Its Acceptance Hereof, Agrees That It Will Not Sell, Transfer or Assign This Purchase Warrant Except as Herein Provided and the Registered Holder of This Purchase Warrant Agrees That It Will Not Sell, Transfer, Assign, Pledge or Hypothecate This Purchase Warrant for a Period of One Hundred Eighty Days Following the Effective Date (Defined Below) to Anyone Other Than (I) Boustead Financial Securities, Inc. Or an Underwriter or a Selected Dealer in Connection With the Offering, or (Ii) a Bona Fide Officer or Partner of Boustead Financial Securiti (April 20th, 2018)

THIS PURCHASE WARRANT IS EXERCISABLE FROM THE DATE OF ISSUANCE. VOID AFTER 5:00 P.M., EASTERN TIME, [*] [ DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING].

Sphere 3D Corp – COMMON SHARE PURCHASE WARRANT SPHERE 3D CORP. (Subject to the Business Corporations Act (Ontario)) (April 17th, 2018)

THIS COMMON SHARES PURCHASE WARRANT (this Warrant) certifies that, for value received, ____________or its assigns (the Holder) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the Initial Exercise Date) and on or prior to the earlier of (i) the close of business on the five (5) year anniversary of the Initial Exercise Date or (ii) subject to applicable notice requirements pursuant to Section 2(f) herein, the effective date of a Fundamental Transaction (as such term is defined in Section 2(d) herein) (the Termination Date; provided, however that if such date is not a Trading Day, the Termination Date shall be the immediately following Trading Day) but not thereafter, to subscribe for and purchase from Sphere 3D Corp., a corporation organized under the laws of the Province of Ontario (the Company), up to ____________Common Shares, no par value per share, of the Company (the Common Sha

COMMON STOCK CLASS a PURCHASE WARRANT Players Network, INC. (March 1st, 2018)

THIS COMMON STOCK CLASS A PURCHASE WARRANT (the "Warrant") certifies that, for value received, Emunah Funding LLC or its registered assigns (the "Holder"), with an address at: 1361 East 10th Street, Brooklyn, NY 11730 Fax: (727) 547-7350, or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on the fifth anniversary of the Issuance Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Players Network, Inc., a Nevada corporation (the "Company"), up to 1,000,000 shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON STOCK CLASS B PURCHASE WARRANT Players Network, INC. (March 1st, 2018)

THIS COMMON STOCK CLASS B PURCHASE WARRANT (the "Warrant") certifies that, for value received, Fourth Man LLC or its registered assigns (the "Holder"), with an address at: 2522 Chambers Road, Suite 100, Tustin, CA 92780, or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on the fifth anniversary of the Issuance Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Players Network, Inc., a Nevada corporation (the "Company"), up to 75,000 shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Auris Medical AG – COMMON SHARE PURCHASE WARRANT AURIS MEDICAL Holding Ag (January 30th, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on January 30, 2025 (the "Termination Date") but not thereafter, to subscribe for and purchase from Auris Medical Holding AG, a company established in Switzerland (the "Company"), up to ______ (as subject to adjustment hereunder, the "Warrant Shares") of registered common shares, nominal value CHF 0.40 per share (each, a "Common Share"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Cytodyn Inc – PURCHASE WARRANT Issued To: Exercisable to Purchase Shares of Common Stock of CYTODYN INC. Warrant No. Void After , 2022 (January 8th, 2018)

This is to certify that, for value received and subject to the terms and conditions set forth below, the Warrantholder is entitled to purchase, and the Company promises and agrees to sell and issue to the Warrantholder, at any time on or after the Initial Exercise Date and on or before the Expiration Date, up to shares of Common Stock at the per share Exercise Price.

The Registered Holder of This Purchase Warrant by Its Acceptance Hereof, Agrees That It Will Not Sell, Transfer or Assign This Purchase Warrant Except as Herein Provided and the Registered Holder of This Purchase Warrant Agrees That It Will Not Sell, Transfer, Assign, Pledge or Hypothecate This Purchase Warrant for a Period of One Hundred Eighty Days Following the Effective Date (Defined Below) to Anyone Other Than (I) Aegis Capital Corp. Or an Underwriter or a Selected Dealer in Connection With the Offering, or (Ii) a Bona Fide Officer or Partner of Aegis Capital Corp. Or of Any Such Underwri (December 18th, 2017)

THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [________________] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING]. VOID AFTER 5:00 P.M., EASTERN TIME, [___________________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING].

Akers Biosciences Inc – The Registered Holder of This Purchase Warrant by Its Acceptance Hereof, Agrees That It Will Not Sell, Transfer or Assign This Purchase Warrant Except as Herein Provided and the Registered Holder of This Purchase Warrant Agrees That It Will Not Sell, Transfer, Assign, Pledge or Hypothecate This Purchase Warrant for a Period of One Hundred Eighty Days Following the Effective Date (Defined Below) to Anyone Other Than (I) Joseph Gunnar & Co., Llc or an Underwriter or a Selected Dealer in Connection With the Offering, or (Ii) a Bona Fide Officer or Partner of Joseph Gunnar & Co., Llc or of Any Suc (December 14th, 2017)

THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [________________] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING]. VOID AFTER 5:00 P.M., EASTERN TIME, [___________________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING].

Ordinary Share Purchase Warrant Rosetta Genomics Ltd. (October 11th, 2017)

THIS ORDINARY SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, [ ] or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October 2, 2017 (the "Initial Exercise Date") and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Rosetta Genomics Ltd., an Israeli corporation (the "Company"), up to [ ] shares (as subject to adjustment hereunder, the "Warrant Shares") of Ordinary Shares, NIS 7.2 par value (the "Ordinary Share(s)"). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Ordinary Share Purchase Warrant Rosetta Genomics Ltd. (October 11th, 2017)

THIS ORDINARY SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, [ ] or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October 2, 2017 (the "Initial Exercise Date") and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Rosetta Genomics Ltd., an Israeli corporation (the "Company"), up to [ ] shares (as subject to adjustment hereunder, the "Warrant Shares") of Ordinary Shares, NIS 7.2 par value (the "Ordinary Share(s)"). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to the Engagement Agreement, dated September 27, 2017, between the Company and H.C. Wainwright & Co., LLC.

PV Nano Cell, Ltd. – Ordinary Share Purchase Warrant (August 22nd, 2017)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, Alpha Capital Anstalt, with an address at: Lettstrasse 32, 9490 Vaduz, Liechtenstein, or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from P.V. NANO CELL LTD., a company formed under the laws of the State of Israel (the "Company"), up to 333,333 shares (as subject to adjustment hereunder, the "Warrant Shares") of Ordinary Shares. The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Eastside Distilling, Inc. – The REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR a PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE EFFECTIVE DATE (DEFINED BELOW) TO ANYONE OTHER THAN: (I) Roth Capital Partners, LLC ("Roth"), Aegis Capital Corp. ("Aegis") or an Underwriter or a Selected Dealer Participating in the Offering; Or (Ii) a Bona Fide Officer or Partner (August 9th, 2017)

THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [________________] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING]. VOID AFTER 5:00 P.M., EASTERN TIME, [___________________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING].